ADC Change In Cash from 2010 to 2024

ADCT Stock  USD 2.03  0.04  2.01%   
ADC Therapeutics Change In Cash yearly trend continues to be comparatively stable with very little volatility. Change In Cash is likely to outpace its year average in 2024. From the period from 2010 to 2024, ADC Therapeutics Change In Cash quarterly data regression had mean square error of 11717.7 T and mean deviation of  96,329,668. View All Fundamentals
 
Change In Cash  
First Reported
2018-03-31
Previous Quarter
65.8 M
Current Value
-25.8 M
Quarterly Volatility
82.8 M
 
Covid
Check ADC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ADC Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 5 M, Depreciation And Amortization of 2.7 M or Interest Expense of 48.6 M, as well as many indicators such as Price To Sales Ratio of 1.85, Dividend Yield of 0.0 or Days Sales Outstanding of 228. ADC financial statements analysis is a perfect complement when working with ADC Therapeutics Valuation or Volatility modules.
  
Check out the analysis of ADC Therapeutics Correlation against competitors.

Latest ADC Therapeutics' Change In Cash Growth Pattern

Below is the plot of the Change In Cash of ADC Therapeutics SA over the last few years. It is ADC Therapeutics' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ADC Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Slightly volatile
   Change In Cash   
       Timeline  

ADC Change In Cash Regression Statistics

Arithmetic Mean61,537,277
Coefficient Of Variation195.21
Mean Deviation96,329,668
Median119,083,000
Standard Deviation120,126,045
Sample Variance14430.3T
Range463.7M
R-Value(0.50)
Mean Square Error11717.7T
R-Squared0.25
Significance0.06
Slope(13,322,078)
Total Sum of Squares202023.7T

ADC Change In Cash History

2024-45.5 M
2023-47.8 M
2022-140.1 M
202127.3 M
2020323.6 M
2019-23.3 M
2018-123.9 M

About ADC Therapeutics Financial Statements

ADC Therapeutics shareholders use historical fundamental indicators, such as Change In Cash, to determine how well the company is positioned to perform in the future. Although ADC Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in ADC Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on ADC Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash-47.8 M-45.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for ADC Stock Analysis

When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.